Literature DB >> 19431231

Confidential enquiries into hypoxic ischaemic encephalopathy.

Eckhart J Buchmann1, Sithembiso C Velaphi.   

Abstract

Hypoxic ischaemic encephalopathy (HIE) may be regarded as a near miss marker for perinatal death resulting from intrapartum hypoxia. Considering the serious long-term consequences of HIE and issues of blame and liability for clinicians, regional or national audit of HIE might best be done using confidential enquiries. These are conducted by independent multidisciplinary panels, and should identify weaknesses in delivery of health care. A confidential enquiry into HIE may determine intrapartum factors that could have caused the poor outcome. It should also consider the role of associated preconceptual and antepartum factors, which may predispose the fetus to intrapartum damage. The enquiry should also assess avoidable factors and suboptimal care. These may involve patient- and family-related problems, administration-related suboptimal care, and health worker-related suboptimal care. The dissemination of the results of confidential enquiries should result in an improvement in quality of health care, including better allocation of health resources and health worker education.

Entities:  

Mesh:

Year:  2009        PMID: 19431231     DOI: 10.1016/j.bpobgyn.2008.12.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  2 in total

1.  Effectiveness of a Novel Continuous Doppler (Moyo) Versus Intermittent Doppler in Intrapartum Detection of Abnormal Foetal Heart Rate: A Randomised Controlled Study in Tanzania.

Authors:  Benjamin Kamala; Hussein Kidanto; Ingvild Dalen; Matilda Ngarina; Muzdalifat Abeid; Jeffrey Perlman; Hege Ersdal
Journal:  Int J Environ Res Public Health       Date:  2019-01-24       Impact factor: 3.390

2.  Confidential enquiries into quality of care of women in labour using Hypoxic Ischemic Encephalopathy as a marker.

Authors:  A De Knijf; R C Pattinson
Journal:  Facts Views Vis Obgyn       Date:  2010
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.